Tag: Thomas Strüngmann
Biontech founders’ cancer drug convinces in study
Ugur Sahin and Özlem Türeci 2018 Before Biontech, Sahin and Türeci founded the Mainz-based biotech company Ganymed. Here they researched a gastric cancer drug whose effectiveness could be proven in…
Start-ups work on the dream of eternal life
Berlin, Frankfort “No voodoo or hocus-pocus” is important to Hartmut Geiger. Mainly because many think of science fiction films when they dream of eternal life. The stem cell researcher and…
Biosimilar biotech company achieves first approval success
Frankfurt It is not every day that German biotech companies receive product approvals for their new drug developments. The Munich Formycon has now achieved such a success both in the…
Formycon wants to become a player in the biosimilar business
In the laboratory After Lucentis, Formycon also wants to launch biosimilars for Stelara and the eye drug Eylea by the middle of the decade. Frankfurt It is not only the…
Major shareholders are considering billion-dollar deal with financial investor
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…
Major shareholders are considering a billion-dollar deal in the pharmaceutical sector
Sandoz Novartis announced in October that it would initiate a strategic review of its generics business, Sandoz. Photo: Sandoz Frankfurt According to circles, the Strüngmann family behind the Covid vaccine…
Wealth at the limit in Munich’s forecourt
Paraglider pilots over the Tegernsee Nowhere else in Germany is the density of billionaires as great as at Tegernsee. (Photo: Reuters) Tegernsee If anyone can explain the situation at Tegernsee,…
Wealth at the limit in Munich’s forecourt
Paraglider pilots over the Tegernsee Nowhere else in Germany is the density of billionaires as great as at Tegernsee. (Photo: Reuters) Tegernsee If anyone can explain the situation at Tegernsee,…